Kyung Nam Pharm Co.,Ltd. (KOSDAQ: A053950)
Health Care · Pharmaceuticals · KR
₩1,999.00
+0.15% today · -31.8% 1Y
Kyung Nam Pharm Co.,Ltd. (KOSDAQ: A053950) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $29.17M.
Over the last twelve months the share price has lost 31.8%, trading between 1.42K and 5.58K.
Tweenvest scores Kyung Nam Pharm Co.,Ltd. across four factors: quality 63/100, value 45/100, growth 0/100. Its strongest factor is quality.
A053950 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $29.17M
- Revenue (TTM)
- $40.56M
- P/E
- —
- EPS
- -575.49
- Dividend yield
- —
- Beta (5Y)
- 0.19
- 52-week high
- ₩5,580.00
- 52-week low
- ₩1,415.00
- Avg volume (3M)
- —
- Shares outstanding
- 19.62M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| New Green Hemp Inc.OTCPK: NGHI | $30.79M | $— | — |
| Aarey Drugs & Pharmaceuticals LimitedBSE: 524412 | $30.64M | Rs104.20 | +1.12% |
| Eagle Veterinary Technology Co.,LtdKOSDAQ: A044960 | $29.95M | ₩3,185.00 | +3.41% |
| Sabaa International Company for Pharmaceutical and Chemical IndustryCASE: SIPC | $29.60M | EGP6.20 | +20.86% |
| IGC Pharma, Inc.NYSEAM: IGC | $28.94M | $0.27 | -3.18% |
| Extrawell Pharmaceutical Holdings LimitedSEHK: 858 | $28.45M | HK$0.08 | -3.75% |
| ZYUS Life Sciences CorporationTSXV: ZYUS | $28.22M | CA$0.50 | -16.67% |
| Context Therapeutics Inc.NasdaqCM: CNTX | $27.95M | $0.31 | +0.79% |
Figures last refreshed Oct 11, 2026.